Global Patent Index - EP 1166775 A3

EP 1166775 A3 20030625 - Targeted liposome gene delivery

Title (en)

Targeted liposome gene delivery

Title (de)

Zielgerichtete Liposomen zur Verabreichung von Genen

Title (fr)

Apport ciblé de gènes dans un liposome vecteur

Publication

EP 1166775 A3 20030625 (EN)

Application

EP 01123562 A 19981119

Priority

  • EP 98958643 A 19981119
  • US 6618897 P 19971119
  • US 8317598 P 19980427

Abstract (en)

[origin: WO9925320A1] Targeted ligand-liposome-therapeutic molecule complexes (vectors) for the systemic delivery of the therapeutic molecule to various target cell types including cancer cells such as squamous cell carcinoma of the head and neck, breast and prostate tumors. The preferred ligands, folate and transferrin, target the liposome complex and facilitate transient gene transfection. The systemic delivery of complexes containing DNA encoding wild-type p53 to established mouse xenografts markedly sensitized the tumors to radiotherapy and chemotherapy. The combination of systemic p53 gene therapy and conventional radiotherapy or chemotherapy resulted in total tumor regression and long term inhibition of recurrence. This cell-specific delivery system was also used in vivo to successfully deliver, via intravenous administration, small DNA molecules (oligonucleotides) resulting in chemosensitivity and xenograft growth inhibition. Other therapeutic molecules, including intact viruses, can be encapsulated in a complex and targeted in accordance with the invention.

IPC 1-7

A61K 9/127; A61K 48/00; C12N 15/88

IPC 8 full level

C12N 15/00 (2006.01); A61K 9/127 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/88 (2006.01)

CPC (source: EP)

A61K 9/1272 (2013.01); A61K 48/0025 (2013.01); A61P 35/00 (2017.12); C12N 15/88 (2013.01); A61K 9/1271 (2013.01); A61K 48/00 (2013.01)

Citation (search report)

  • [Y] US 5635380 A 19970603 - NAFTILAN ALLEN J [US], et al
  • [A] WO 9521259 A1 19950810 - US HEALTH [US], et al
  • [A] WANG S ET AL: "Delivery of antisense oligonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, April 1995 (1995-04-01), pages 3318 - 3322, XP002098092, ISSN: 0027-8424
  • [Y] XU L ET AL: "Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro", HUMAN GENE THERAPY, XX, XX, vol. 8, no. 4, 1 March 1997 (1997-03-01), pages 467 - 475, XP002098089, ISSN: 1043-0342
  • [A] SIMOES S ET AL: "Enhancement of cationic liposome-mediated gene delivery by transferrin and fusogenic peptides", PROCEEDINGS OF THE 24TH. INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS. STOCKHOLM, JUNE 15 - 19, 1997, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, DEERFIELD, IL., CONTROLLED RELEASE, vol. SYMP. 24, 15 June 1997 (1997-06-15), pages 659 - 660, XP002098090, ISSN: 1022-0178

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9925320 A1 19990527; AT E295722 T1 20050615; AT E459340 T1 20100315; AU 1464299 A 19990607; AU 759164 B2 20030410; AU 759164 C 20070329; CA 2308584 A1 19990527; CA 2308584 C 20110719; CN 1191094 C 20050302; CN 1286630 A 20010307; CN 1616665 A 20050518; CN 1616665 B 20101006; CN 1904055 A 20070131; DE 69830249 D1 20050623; DE 69830249 T2 20060504; DE 69841536 D1 20100415; DK 1166775 T3 20100503; EP 1032369 A1 20000906; EP 1032369 B1 20050518; EP 1166775 A2 20020102; EP 1166775 A3 20030625; EP 1166775 B1 20100303; ES 2339421 T3 20100520; HK 1035490 A1 20011130; HK 1045641 A1 20021206; HK 1045641 B 20101029; HK 1078608 A1 20060317; JP 2001522871 A 20011120; JP 2010263920 A 20101125; PT 1166775 E 20100416

DOCDB simple family (application)

US 9824657 W 19981119; AT 01123562 T 19981119; AT 98958643 T 19981119; AU 1464299 A 19981119; CA 2308584 A 19981119; CN 200410082473 A 19981119; CN 200610100325 A 19981119; CN 98813177 A 19981119; DE 69830249 T 19981119; DE 69841536 T 19981119; DK 01123562 T 19981119; EP 01123562 A 19981119; EP 98958643 A 19981119; ES 01123562 T 19981119; HK 01106017 A 20010827; HK 02104922 A 20020702; HK 05110310 A 20051117; JP 2000520754 A 19981119; JP 2010184261 A 20100819; PT 01123562 T 19981119